Allan Moffitt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Allan Moffitt has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Katrina. K. Poppe
Department of Medicine, University of Auckland, Auckland, New Zealand
3 shared publications - Susan Wells
School of Population Health, Faculty of Medical and Health Sciences, University of Auckland , Auckland 1142
3 shared publications - Yeunhyang Catherine Choi
The University of Auckland Faculty of Medical and Health Sciences, Epidemiology & Biostatistics, Auckland, New Zealand
3 shared publications - Jane Ullmer
School of Population Health, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
2 shared publications - Vanessa Selak
Section of Epidemiology and Biostatistics, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand
2 shared publications - Claris Chung
University of Canterbury
1 shared publication
Latest Publications
- Open Access
- 7 May 2026
- Published by Royal College of General Practitioners in British Journal of General Practice
Multimorbidity and cardiovascular prevention in primary care: Cohort study in New Zealand
Background: Multimorbidity adds complexity to medication management. National guidelines in New Zealand (NZ) recommend dual therapy with blood-pressure- and lipid-lowering agents for most patients at five-year cardiovascular disease (CVD) risk ≥15% (high risk), considered at 5-14% (intermediate risk), and not generally recommended at <5% (low risk). Aim: To examine the association between multimorbidity and dispensing of dual therapy across risk strata. Design and setting: A cohort study among 430,286 patients aged 30-79 years without prior CVD, enrolled in the NZ Primary Health Organisation ProCare in 2014. Method: Multivariable Poisson regression estimated relative risks (RR) for dual therapy across CVD risk groups at cohort entry. Two-year maintenance of dual therapy was then compared by multimorbidity within each risk stratum. Results: Baseline dual therapy receipt was 1.5%, 31% and 40% in low, intermediate and high risk groups respectively. Multimorbidity was associated with greater use of dual therapy across risk groups (low risk: RR 2.90 [95% CI 2.77-3.03]; intermediate risk: RR 1.35 [95% CI 1.32-1.38]; high risk: RR 1.15 [95% CI 1.10-1.22]). Multimorbidity was also associated with higher maintenance in the low (88% vs 84%) and intermediate (90% vs 86%) risk groups (both p<0.001) and was high, irrespective of multimorbidity, in high risk (89% vs 88%; p=0.415). Conclusion: Patients with multimorbidity were more likely than others to be commenced on and maintain CVD prevention. However, while dispensing increased with increasing CVD risk, a large evidence-practice gap in dual therapy remained for those at high CVD risk. Keywords: General practice; Multimorbidity; Cardiovascular preventive medication
- 7 May 2026
- Published by Royal College of General Practitioners in British Journal of General Practice
Open AccessMultimorbidity and cardiovascular prevention in primary care: Cohort study in New Zealand
Background: Multimorbidity adds complexity to medication management. National guidelines in New Zealand (NZ) recommend dual therapy with blood-pressure- and lipid-lowering agents for most patients at five-year cardiovascular disease (CVD) risk ≥15% (high risk), considered at 5-14% (intermediate risk), and not generally recommended at <5% (low risk). Aim: To examine the association between multimorbidity and dispensing of dual therapy across risk strata. Design and setting: A cohort study among 430,286 patients aged 30-79 years without prior CVD, enrolled in the NZ Primary Health Organisation ProCare in 2014. Method: Multivariable Poisson regression estimated relative risks (RR) for dual therapy across CVD risk groups at cohort entry. Two-year maintenance of dual therapy was then compared by multimorbidity within each risk stratum. Results: Baseline dual therapy receipt was 1.5%, 31% and 40% in low, intermediate and high risk groups respectively. Multimorbidity was associated with greater use of dual therapy across risk groups (low risk: RR 2.90 [95% CI 2.77-3.03]; intermediate risk: RR 1.35 [95% CI 1.32-1.38]; high risk: RR 1.15 [95% CI 1.10-1.22]). Multimorbidity was also associated with higher maintenance in the low (88% vs 84%) and intermediate (90% vs 86%) risk groups (both p<0.001) and was high, irrespective of multimorbidity, in high risk (89% vs 88%; p=0.415). Conclusion: Patients with multimorbidity were more likely than others to be commenced on and maintain CVD prevention. However, while dispensing increased with increasing CVD risk, a large evidence-practice gap in dual therapy remained for those at high CVD risk. Keywords: General practice; Multimorbidity; Cardiovascular preventive medication
- Open Access
- 16 February 2026
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 8 (1) , 35
Frequency of Migraine Recorded in Primary Care and Hospital Records in Aotearoa New Zealand: a Cross-Sectional Study
Background/Objective: Migraine is the second most disabling condition worldwide affecting over one billion people. We aimed to investigate the frequency of recorded migraine utilising general practice and hospital admission data, comparing this with population-based prevalence estimates for Aotearoa New Zealand (NZ). Methods: From the electronic health record of de-identified data for 374,071 men and women aged 18 and over enrolled as of 2014 in NZ general practices, any entry of recorded migraine from a patient’s visit to primary care or hospital facility recorded using Read codes, Read terms, or free text entries was extracted. Via an encrypted National Health Identifier (NHI), individual patient linkage identified migraine coded in the national hospitalisation dataset, enabling exploration by gender, age group, ethnicity and NZ deprivation index quintile. Results: Compared to population prevalence (15%), 4.8% of this cohort had recorded migraine (79% in general practice only; 14% in hospital records only; 7.5% in both primary and secondary care). Women (6.7%) had higher recording than men (2.5%), with the highest age-specific recording at 45–54 years (women 7.4%, men 2.7%). By gender and ethnicity, migraine recording was highest for European women (7.9%). Within quintile 5 communities (most deprived), recording was significantly lower for females ( p < 0.0001) and males ( p = 0.03) than in quintiles 1–4. Conclusions: This study is the first to estimate migraine in NZ using linked primary and secondary care data. As well as highlighting age-, gender-, and ethnicity-specific differences, the underestimate of diagnosis compared to self-reported survey data is likely due to health care access, under-reporting, under-diagnosis, under-recording, and knowledge gaps about migraine symptoms and therapies.
- 16 February 2026
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 8 (1) , 35
Open AccessFrequency of Migraine Recorded in Primary Care and Hospital Records in Aotearoa New Zealand: a Cross-Sectional Study
Background/Objective: Migraine is the second most disabling condition worldwide affecting over one billion people. We aimed to investigate the frequency of recorded migraine utilising general practice and hospital admission data, comparing this with population-based prevalence estimates for Aotearoa New Zealand (NZ). Methods: From the electronic health record of de-identified data for 374,071 men and women aged 18 and over enrolled as of 2014 in NZ general practices, any entry of recorded migraine from a patient’s visit to primary care or hospital facility recorded using Read codes, Read terms, or free text entries was extracted. Via an encrypted National Health Identifier (NHI), individual patient linkage identified migraine coded in the national hospitalisation dataset, enabling exploration by gender, age group, ethnicity and NZ deprivation index quintile. Results: Compared to population prevalence (15%), 4.8% of this cohort had recorded migraine (79% in general practice only; 14% in hospital records only; 7.5% in both primary and secondary care). Women (6.7%) had higher recording than men (2.5%), with the highest age-specific recording at 45–54 years (women 7.4%, men 2.7%). By gender and ethnicity, migraine recording was highest for European women (7.9%). Within quintile 5 communities (most deprived), recording was significantly lower for females ( p < 0.0001) and males ( p = 0.03) than in quintiles 1–4. Conclusions: This study is the first to estimate migraine in NZ using linked primary and secondary care data. As well as highlighting age-, gender-, and ethnicity-specific differences, the underestimate of diagnosis compared to self-reported survey data is likely due to health care access, under-reporting, under-diagnosis, under-recording, and knowledge gaps about migraine symptoms and therapies.
- Open Access
- 22 May 2025
- Published by BMJ in BMJ Health & Care Informatics
- Vol. 32 (1) , e101393
Identifying long-term conditions in New Zealand general practice using structured and unstructured data: a cross-sectional study
Objectives: This study examined whether incorporating free-text entries into structured general practice records improves the detection of long-term conditions (LTCs) and multimorbidity (MM) in New Zealand (NZ) general practices. Methods: Data from 374 071 deidentified individuals in general practices were analysed to identify 61 LTCs. Structured data were extracted using Read codes from a national master list, and clinical raters independently identified condition-related free-text, including synonyms, negation terms and common misspellings in randomised samples. Keywords were categorised and refined through ten iterative tests. Programmatic text classification was developed and assessed against gold-standard clinician ratings, using sensitivity, specificity, positive predictive value (PPV) and F 1 -score. Results: A quarter of general practitioner classifications contained either unrecognised Read codes or consisted of free-text only. Clinician inter-rater reliability was high (kappa ≥0.9). Compared with clinical gold standard, text classification yielded an average sensitivity of 88%, specificity of 99% and PPV of 95%, with an F 1 -score range of 82%–95%. Incorporating free text increased LTC prevalence from 42.1% to 46.3%, reducing misclassification of MM diagnoses by identifying 12 626 additional patients with MM and 15 972 additional patients with at least one LTC. Discussion: In the course of workflow, general practitioners face barriers to accurate LTC coding or may simply annotate with text-based descriptions. Programmatic text classification has demonstrated high performance and identified many more patients receiving LTC care. Conclusions: Combining structured and unstructured data optimises MM detection in NZ general practices and has the potential to improve case management, follow-up care and allocation of healthcare resources.
- 22 May 2025
- Published by BMJ in BMJ Health & Care Informatics
- Vol. 32 (1) , e101393
Open AccessIdentifying long-term conditions in New Zealand general practice using structured and unstructured data: a cross-sectional study
Objectives: This study examined whether incorporating free-text entries into structured general practice records improves the detection of long-term conditions (LTCs) and multimorbidity (MM) in New Zealand (NZ) general practices. Methods: Data from 374 071 deidentified individuals in general practices were analysed to identify 61 LTCs. Structured data were extracted using Read codes from a national master list, and clinical raters independently identified condition-related free-text, including synonyms, negation terms and common misspellings in randomised samples. Keywords were categorised and refined through ten iterative tests. Programmatic text classification was developed and assessed against gold-standard clinician ratings, using sensitivity, specificity, positive predictive value (PPV) and F 1 -score. Results: A quarter of general practitioner classifications contained either unrecognised Read codes or consisted of free-text only. Clinician inter-rater reliability was high (kappa ≥0.9). Compared with clinical gold standard, text classification yielded an average sensitivity of 88%, specificity of 99% and PPV of 95%, with an F 1 -score range of 82%–95%. Incorporating free text increased LTC prevalence from 42.1% to 46.3%, reducing misclassification of MM diagnoses by identifying 12 626 additional patients with MM and 15 972 additional patients with at least one LTC. Discussion: In the course of workflow, general practitioners face barriers to accurate LTC coding or may simply annotate with text-based descriptions. Programmatic text classification has demonstrated high performance and identified many more patients receiving LTC care. Conclusions: Combining structured and unstructured data optimises MM detection in NZ general practices and has the potential to improve case management, follow-up care and allocation of healthcare resources.
- Open Access
- 25 June 2024
- Published by CSIRO Publishing in Journal of Primary Health Care
- Vol. 16 (2) , 220-223
Substitution of regulated health professionals, such as doctors and nurses, with unregulated health care workers, such as physician assistants, gives rise to concerns around patient safety and accountability issues: No
- 25 June 2024
- Published by CSIRO Publishing in Journal of Primary Health Care
- Vol. 16 (2) , 220-223
Open AccessSubstitution of regulated health professionals, such as doctors and nurses, with unregulated health care workers, such as physician assistants, gives rise to concerns around patient safety and accountability issues: No